Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Randa AlOkka, Ruba Yasin Taha, Honar Cherif, Safaa Alazawi, Mohammad Bakir, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7128.

https://doi.org/10.1182/blood-2025-7128

Published: 2025

Journal Articles

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Ghasoub Rola, Maria Benkhadra, Laila Shafei, Sara Aldali, Layali Bakir, Anas Hamad, Saad Laws, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 5548.

https://doi.org/10.1182/blood-2025-5548

Published: 2025

Journal Articles

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2025-7264

Published: 2025

Journal Articles

Real-world assessment of early toxicities, treatment modifications, and outcomes with daratumumab, bortezomib, lenalidomide, and dexamethasone (D-VRd) in multiple myeloma

Hesham Elsabah, Ghasoub Rola, Anas Hamad, Maria Benkhadra, Aya Alasmar, Amaal Gulied, Deena Mudawi, Hawraa Shawaylia, Mohammad Bakir, Honar Cherif

Blood (2025) 146 (Supplement 1): 7508.

https://doi.org/10.1182/blood-2025-7508

Published: 2025

Journal Articles

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif

Blood (2025) 146 (Supplement 1): 6662.

https://doi.org/10.1182/blood-2025-6662

Published: 2025

Journal Articles

Impact of tyrosine kinase inhibitors on estimated glomerular filtration rate in chronic myeloid leukemia patients

Awni Alshurafa, Nabeel Qasem, Anas Babiker, Maria Benkhadra, Yousef Al-Asa'd, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 7306.

https://doi.org/10.1182/blood-2025-7306

Published: 2025

Journal Articles

Genomic insights and risk stratification in AML: Findings from a uniquely young national cohort in Qatar (AML-QC)

Amna Gameil, Mahmoud Hailk, Feryal Hilmi, Maria Benkhadra, Wafa Mohammed, Afraa Fadul, Salma Suliman, Farah Jibril, Samah Kohla, Mohamed Ibrahim, LAYLA MOHAMED, Amaal Gulied, Muna Al Zeyara, Hesham Elsabah, Amal Aly, Anas Hamad, Kalpana Singh, Honar Charif

Blood (2025) 146 (Supplement 1): 6928.

https://doi.org/10.1182/blood-2025-6928

Published: 2025

Journal Articles

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Mohammad Bakir, Hesham Elsabah, Layali Bakir, Rajvir Singh, Honar Cherif, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 6348.

https://doi.org/10.1182/blood-2025-6348

Published: 2025

Journal Articles

A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population

Ghasoub Rola, Hesham Elsabah, Layaly Bakir, Maria Benkhadra, Liam Fernyhough, Awni Alshurafa, Salma Mustafa, Rajvir Singh, Honar Cherif, Mohammad Bakr

Blood (2024) 144 (Supplement 1): 7719.

https://doi.org/10.1182/blood-2024-204728

Published: 2024

Journal Articles

Renal Adverse Events in Chronic Myeloid Leukemia: Can the Exposure to One TKI be the Culprit?

Reem Hajeomar, Maria Benkhadra, Rola Ghasoub, Jorge E. Cortes, Giuseppe Saglio, Awni Alshurafa, Nabeel Qasem, Islam Elkonaissi, Rasha Kaddoura, Mohamed A Yassin

Blood (2024) 144 (Supplement 1): 7920.

https://doi.org/10.1182/blood-2024-206775

Published: 2024

Journal Articles

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia : A Systematic Review

Amna Gameil, Rola Ghasoub, Neda Jafari, Laila Shafei, Maria Benkhadra, Saad Laws, Liam Fernyhough

Blood (2024) 144 (Supplement 1): 6592.

https://doi.org/10.1182/blood-2024-203919

Published: 2024

Journal Articles

Permissibility of an Intermittent Fasting in Patients with Chronic Lymphocytic Leukemia in the Era of Novel Therapies :a Pharmacology Based Review

Maria Benkhadra, Nuha Fituri, Soha Aboukhalaf, Rola Ghasoub, Mervat Mattar, Khalil Al Farsi, Salem Alshemmari, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 6559.

https://doi.org/10.1182/blood-2023-178185

Published: 2023

Journal Articles

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Rola Ghasoub, Shereen Elazzazy, Maria Benkhadra, Nancy Kassem, Honar Cherif, Javid Gaziev, Hesham Elsabah, Anas Ahmad Hamad

Blood (2023) 142 (Supplement 1): 5079.

https://doi.org/10.1182/blood-2023-185615

Published: 2023

Journal Articles

Transplant Associated Thrombotic Microangiopathy: Acomprehensive Review and Local Experience

Maria Benkhadra, Amaal Gulied, Mohamed Saeed Mohamed, Deena Mudawi, Javid Gaziev, Murtadha Al-Khabori, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 7116.

https://doi.org/10.1182/blood-2023-184374

Published: 2023

Journal Articles

Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

Maria Benkhadra, Shereen Elazzazy, Anas Ahmad Hamad, Mohamed S. Elkhatim, Amaal Gulied, Arwa Osama Sahal, Aya Alasmar, Farah I. Jibril, Hebatalla Mahmoud Afifi, Sahar Nasser, Afnan Alnajjar, Rawan Dawoud, Nabil E. Omar

Blood (2023) 142 (Supplement 1): 5378.

https://doi.org/10.1182/blood-2023-180648

Published: 2023

Journal Articles

Pregnancy in Patents with CLL Systematic Review

Ahmed Abdelrehim Badr, Maria Benkhadra, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 6555.

https://doi.org/10.1182/blood-2023-178193

Published: 2023

Journal Articles

The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia

Fateen Ata, Rola Ghasoub, Maria Benkhadra, Liam Fernyhough, Mahmood Aldapt, Nabil E. Omar, Abdulqadir Nashwan, Kamran Mushtaq, Mohamed A Yassin

Blood (2023) 142 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2023-179341

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Real-world assessment of early toxicities, treatment modifications, and outcomes with daratumumab, bortezomib, lenalidomide, and dexamethasone (D-VRd) in multiple myeloma

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Impact of tyrosine kinase inhibitors on estimated glomerular filtration rate in chronic myeloid leukemia patients

Genomic insights and risk stratification in AML: Findings from a uniquely young national cohort in Qatar (AML-QC)

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population

Renal Adverse Events in Chronic Myeloid Leukemia: Can the Exposure to One TKI be the Culprit?

Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia : A Systematic Review

Permissibility of an Intermittent Fasting in Patients with Chronic Lymphocytic Leukemia in the Era of Novel Therapies :a Pharmacology Based Review

Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar

Transplant Associated Thrombotic Microangiopathy: Acomprehensive Review and Local Experience

Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar

Pregnancy in Patents with CLL Systematic Review

The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only